
==== Front
Biotherapy
Biotherapy
Biotherapy (Dordrecht, Netherlands)
0921-299X 1573-8280 Kluwer Academic Publishers Dordrecht 

2054257
BF02172089
10.1007/BF02172089
Article
Evaluation of TNF as antiviral, antibacterial and antiparasitic agent
Rook Graham A. W. 1 Taverne Janice 2 Playfair John H. L. 2 1 grid.83440.3b0000000121901201Department of Medical Microbiology, University College and Middlesex School of Medicine, Ridinghouse St, W1P 7PP London, UK 
2 grid.83440.3b0000000121901201Department of Immunology, University College and Middlesex School of Medicine, W1 London, UK 
1991 
3 2 167 175
© Kluwer Academic Publishers 1991This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Key words
bacteriaparasitesprotectionTNFvirusissue-copyright-statement© Kluwer Academic Publishers 1991
==== Refs
References
1. Havell EA   Production of tumor necrosis factor during murine listeriosis J Immunol 1987 139 4225 31 3693903 
2. Nakane A  Minagawa T  Kato K   Endogeneous tumour necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection Infect Immun 1988 56 2563 9 3138177 
3. Bancroft GJ  Sheehan KC  Schreiber RD  Unanue ER   Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice J Immunol 1989 143 127 30 2499625 
4. Kindler V  Sappino AP  Grau GE  Piguet PF  Vassalli P   The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection Cell 1989 56 731 40 2647299 
5. Neifer S  Kremsner PG  Bienzle U   Application of anti-TNF to plasmodium vinckei-infected mice is followed by an increase of parasitaemia Acta Trop (Basel) 1989 46 273 5 2571256 
6. Titus RG  Sherry B  Cerami A   Tumour necrosis factor plays a protective role in experimental murine cutaneous leismaniasis J exp Med 1989 170 2097 104 2584936 
7. Taverne J  Tavernier J  Fiers W  Playfair JH   Recombinant tumour necrosis factor inhibits malaria parasitein vivo  but notin vitro  Clin Exp Immunol 1987 67 1 4 3621669 
8. Clark IA  Hunt NH  Butcher GA  Cowden WB   Inhibition of murine malaria (plasmodium chabaudi)in vivo  by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole J Immunol 1987 139 3493 6 3119710 
9. Black CM  Israelski DM  Suzuki Y  Remington JS   Effect of recombinant tumour necrosis factor on acute infection in mice with toxoplasma gondii or Trypanosoma cruzi Immunology 1989 68 570 4 2514141 
10. Bermudez LEM  Stevens P  Kolonoski P  Wu M  Young LS   Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor J Immunol 1989 143 2996 3000 2553816 
11. Blanchard DK  Djeu JY  Klein TW  Friedman H  Stewart WE   Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function J Leukoc Biol 1988 43 429 35 3163717 
12. Parant M   Effects of TNF in bacterial infections Ann Inst Pasteur Immunol 1988 139 301 4 3048313 
13. Cross AS  Sadoff JC  Kelly N  Bernton E  Gemski P   Pretreatment with recombinant murine tumour necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection J Exp Med 1989 169 2021 7 2659724 
14. Tracey KJ  Fong Y  Hesse DG  Manogue KR  Lee AT  Kuo GC  Lowry SF  Cerami A   Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 1987 330 662 4 3317066 
15. Doherty PC  Allan JE  Clark IA   Tumour necrosis factor inhibits the development of viral meningitis or induces rapid death depending on the severity of inflammation at the time of administration J Immunol 1989 142 3576 80 2715635 
16. Kongshavn PA  Ghadirian E   Effect of tumour necrosis factor on growth of Trypanosoma musculiin vivo  andin vitro  Adv Exp Biol Med 1988 239 257 62 
17. Usami H  Yamamoto A  Yamashita W  Sugawara Y  Hamada S  Yamamoto T  Kato K  Kokeguchi S  Ohokuni H  Kotani S   Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma Br J Cancer 1988 57 70 3 3279996 
18. Moreno C  Taverne J  Mehlert A  Bate CA  Brealey RJ  Meager A  Rook GAW  Playfair JHL   Lipoarabinomannan from mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages Clin Exp Immunol 1989 76 240 5 2503277 
19. Jupin C  Anderson S  Damais C  Alouf JE  Parant M   Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon J Exp Med 1988 167 752 61 3127526 
20. Yamamoto A  Nagamuta M  Usami H  Sugawara Y  Watanabe N  Niitsu Y  Urushizaki I   Release of tumour necrosis factor (TNF) into mouse peritoneal fluids by OK432, a streptococcal preparation Immunopharmacology 1986 11 79 86 3710767 
21. Noso Y  Parant M  Parant F  Chedid L   Production of tumour necrosis factor in nude mice by muramyl peptides associated with bacterial vaccines Cancer Res 1988 48 5766 9 3167834 
22. Bate CA  Taverne J  Playfair JH   Soluble malarial antigens are toxic and induce the production of tumour necrosis factorin vivo  Immunology 1989 66 600 5 2654012 
23. Djeu JY  Blanchard DK  Richards AL  Friedman H   Tumor necrosis factor induction by candida albicans from human natural killer cells and monocytes J Immunol 1988 141 4047 52 3053905 
24. Playfair JHL  Taverne J  Bate CAW  De Souza JB   The malaria vaccine: anti-parasite or anti-disease? Immunology Today 1990 11 25 7 2405875 
25. Roux-Lombard P, Modoux C, Cruchaud A, Dayer JM. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin Immunol Immunopathol 50: 374-84.
26. Molina JM  Scadden DT  Byrn R  Dinarello CA  Groopman JE   Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus J Clin Invest 1989 84 733 7 2474573 
27. Merrill JE  Koyanagi Y  Chen IS   Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor J Virol 1989 63 4404 8 2789293 
28. Klebanoff SJ  Vadas MA  Harlan JM  Sparks LH  Gamble JR  Agosti JM  Waltersdorf AM   Stimulation of neurophils by tumour necrosis factor J Immunol 1986 136 4220 5 3009619 
29. Berkow RL  Dodson MR   Biochemical mechanisms in the priming of neutrophils by tumour necrosis factor J Leukocyte Biol 1988 44 345 52 2846726 
30. Ferrante A   Tumor necrosis factor alpha potentiates neutrophil antimicrobial and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release Infect Immun 1989 57 2115 22 2659536 
31. Gamble JR  Harlan JM  Klebanoff SJ  Vadas MA   Stimulation of the adherence of neutrophils to the umbilical vein endothelium by human recombinant tumour necrosis factor Proc Natl Acad Sci USA 1985 82 8667 71 3866246 
32. Shalaby MR  Aggarwal BB  Rinderknecht E  Svedersky LP  Finkle BS  Palladino MA   Activation of human polymorphonuclear functions by interferon gamma and tumor necrosis factors J Immunol 1985 135 2069 73 3926894 
33. Shalaby MR  Palladino MA  Hirabayashi SE  Eesalu TE  Lewis GD  Shepard HM  Aggarwal BB   Receptor binding and activation of polymorphonuclear neutrophils by tumour necrosis factor alpha J Leukocyte Biol 1987 41 196 204 3031189 
34. Djeu JY  Blanchard DK  Halkias D  Friedman H   Growth inhibition of candida albicans by human polymorphonuclear neutrophils: activation by interferon gamma and tumor necrosis factor J Immunol 1986 137 2980 4 3093587 
35. Damonneville M  Wietzerbin J  Pancre V  Joseph M  Delanoye A  Capron A  Auriault C   Recombinant tumour necrosis factors mediate platelet cytotoxicity to schistosoma mansoni larvae J Immunol 1988 140 3962 5 3131420 
36. DeTitto EH  Catterall JR  Remington JS   Activity of recombinant tumour necrosis factor on toxoplasma gondii and trypanosoma cruzi J Immunol 1986 137 1342 5 3525677 
37. Wirth JJ  Kierszenbaum F   Recombinant tumour necrosis factor enhances macrophage destruction of trypanosoma cruzi in the presence of bacterial endotoxin J Immunol 1988 141 286 8 3288698 
38. Bermudez LE  Young LS   Tumour necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of mycobacterium avium complex J Immunol 1988 140 3006 13 2834450 
39. Rook GAW  Steele J  Ainsworth M  Champion BR   Activation of macrophages to inhibit proliferation of mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages Immunology 1986 59 333 8 3098676 
40. Voth R  Rossol S  Gallati H  Pracht I  Laubenstein HP  Hess G  Muller WE  Schroder HC  Jochum C  Meyer-zum-Buschenfelde KH   In vivo  andin vitro  induction of natural killer cells by cloned human tumour necrosis factor Cancer Immunol Immunother 1988 27 128 32 2458181 
41. Silberstein DS  David JR   Tumour necrosis factor enhances eosinophil toxicity of schistosoma mansoni larvae Proc Natl Acad Sci USA 1986 83 1055 9 3456562 
42. Whitcombe EA  Wesolek JH  Pincus SH   Modulation of human peripheral blood eosinophil function by tumour necrosis factor alpha Int Arch Allergy Appl Immunol 1989 89 250 5 2547724 
43. Alam R  Welter JB  Forsythe PA  Lett-Brown MA  Grant JA   Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN- gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histaminereleasing factors on the secretion of histamine from basophils J Immunol 1989 142 3431 5 2469713 
44. Deare M  Bukholm G  Czarniecki CW   In vitro  treatment of HEp-2 cells with human tumour necrosis factor alpha and human interferons reduces invasiveness of salmonella typhimurium J Biol Regul Homeost Agents 1989 3 1 7 2472042 
45. Shemer-Avni Y  Wallach D  Sarov I   Reversion of the antichlamydial effect of tumour necrosis factor by tryptophan and antibodies to beta interferon Infect Immun 1989 57 3484 90 2509363 
46. Mestan J  Digel W  Mittnacht S  Hillen H  Blohm D  Moller A  Jacobsen H  Kirchner H   Antiviral effect of recombinant tumour necrosis factorin vitro  Nature 1986 323 816 9 3022155 
47. Wong GHW  Goeddel DV   Tumour necrosis factors alpha and beta inhibit virus replication and synergise with interferons Nature 1986 323 819 22 2430188 
48. Ruggiero V  Antonelli G  Conciatori G  Gentile M  Van Damme J  Dianzani F   Thein vitro  antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-beta induction Antiviral Res 1989 11 77 88 2543288 
49. Janssen O  Kabelitz D   Tumour necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus J Immunol 1988 140 125 30 2826585 
50. Koff WC  Farm AV   Human tumour necrosis factor alpha kills herpesvirus-infected, but not normal cells Lymphokine Res 1986 5 215 21 3747602 
51. Matsuyama T  Hamamoto Y  Soma G  Mizuno D  Yamamoto N  Kobayashi N   Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication J Virol 1989 63 2504 9 2470917 
52. Kasahara K  Kobayashi K  Shikama Y  Yoneva I  Kaga S  Hashimoto M  Odagiri T  Soejima K  Ide H  Takahashi T   The role of monokines in granuloma formation in mice: the ability of interleukin-1 and tumour necrosis factor alpha to induce lung granulomas Clin Immunol Immunopathol 1989 51 419 25 2785886 
53. Sheppard BC  Fraker DL  Norton JA   Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor Surgery 1989 106 156 61 2669193 
54. Brouckaert P  Spriggs DR  Demetri G  Kufe DW  Fiers W   Circulating Interleukin 6 during an infusion of tumour necrosis factor and interferon gamma J exp Med 1989 169 2257 62 2499657 
55. Baumann H  Wong GW   Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor J Immunol 1989 143 1163 7 2473120 
56. Waage A  Halstensen A  Espevik T   Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease Lancet 1987 1 355 7 2880163 
57. Millar AB  Foley NM  Singer M  Johnson NMCI  Meager A  Rook GAW   TNF in bronchopulmonary secretions of patients with adult respiratory distress syndrome Lancet 1989 ii 712 4 
58. Kern P  Hemmer CJ  Van-Damme J  Gruss HJ  Dietrich M   Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated plasmodium facciparum malaria Am J Med 1989 87 139 43 2667356 
59. Clark IA  Chaudhri G   Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis Br J Haematol 1988 70 99 103 3179231 
60. Clark IA  Chaudhri G   Tumor necrosis factor in malaria-induced abortion Am J Trop Med Hyg 1988 39 246 9 3177738 
61. Grau GE  Fajardo LF  Piguet PF  Allet B  Lambert PH  Vassalli P   Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria Science 1987 237 1210 2 3306918 
62. Mintz M  Rapaport R  Oleske JM  Connor EM  Koenigsberger MR  Denny T  Epstein LG   Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome Am J Dis Child 1989 143 771 4 2741845 
63. Folks TM  Clouse KA  Justement J  Rabson A  Duh E  Kehrl JH  Fauci AS   Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone Proc Natl Acad Sci USA 1989 86 2365 8 2784570 
64. Okamoto T  Matsuyama T  Mori S  Hamamoto Y  Kobayashi N  Yamamoto N  Josephs SF  Wong-Staal F  Shimotohno K   Augmentation of human immunodeficiency virus type I gene expression by tumor necrosis factor alpha AIDS Hum Retroviruses 1989 5 131 8 
65. Ito M  Baba M  Sato A  Hirabayashi K  Tanabe F  Shigeta S  De-Clercq E   Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV)in vitro  Biochem Biophys Res Commun 1989 158 307 12 2912452 
66. Duh EJ  Maury WF  Folks TM  Fauci AS  Rabson AB   Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat Proc Natl Acad Sci USA 1989 86 5974 8 2762307 
67. Aboulafia D  Miles SA  Saks SR  Mitsuyasu RT   Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma J Acquir Immune Defic Syndr 1989 2 54 8 2918461 
68. Tracey KJ  Wei H  Manogue KR  Fong Y  Hesse DG  Nguyen HT  Kuo GC  Beutler B  Cotran RS  Cerami A   Cachectin/tumor necrosis factor induces cachexia, anaemia, and inflammation J Exp Med 1988 167 1211 27 3351436 
69. Waage A  Espevik T   Interleukin-I potentiates the lethal effect of tumour necrosis factor alpha/cachectin in mice J Exp Med 1988 167 1987 92 3290384 
70. Rothstein J  Schreiber H   Synergy between tumour necrosis factor and bacterial products causes haemorrhagic necrosis and lethal shock in normal mice Proc Natl Acad Sci 1988 85 607 11 3422444 
71. Rook GAW  Taverne J  Leveton C  Steele J   The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis Immunology 1987 62 229 34 3119471 
72. Rook GAW   The role of cytokines in the immunopathology of tuberculosis and the regulation of agalactosyl IgG Lymphokine Research 1989 8 323 8 2674558 
73. Pober JS   TNF as an activator of vascular endothelium Ann Inst Pasteur Immunol 1988 139 317 23 3048316 
74. Aderka D  Levo Y   Does tumor necrosis factor play a role in the pathogenesis of fulminant hepatitis Med Hypotheses 1988 27 193 6 2463460 
75. Wallach D  Holtmann H  Engelmann H  Nophar Y   Sensitisation and desensitisation to lethal effects of tumour necrosis factor and IL-1 J Immunol 1988 140 2994 9 3258889 
76. Kiener PA  Marek F  Rodgers G  Lin PF  Warr G  Desiderio J   Induction of tumour necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A J Immunol 1988 141 870 4 3135314

